BO
The startup develops a breath-analysis technology that detects volatile and non-volatile organic compounds in human breath using a proprietary algorithm. This enables rapid, noninvasive identification of diseases such as COVID-19, cancer, and Alzheimer's, facilitating early medical intervention.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a breath-analysis technology that detects volatile and non-volatile organic compounds in human breath using a proprietary algorithm. This enables rapid, noninvasive identification of diseases such as COVID-19, cancer, and Alzheimer's, facilitating early medical intervention.